Search Page

1

Cite

Share

Stabilization of exosome-targeting peptides via engineered glycosylation.

Hung ME, Leonard JN. Hung ME, et al. J Biol Chem. 2015 Mar 27;290(13):8166-72. doi: 10.1074/jbc.M114.621383. Epub 2015 Feb 5. J Biol Chem. 2015. PMID: 25657008 Free PMC article.

Cite

Share

2

Cite

Share

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.

Weichselbaum RR, Ishwaran H, Yoon T, Nuyten DS, Baker SW, Khodarev N, Su AW, Shaikh AY, Roach P, Kreike B, Roizman B, Bergh J, Pawitan Y, van de Vijver MJ, Minn AJ. Weichselbaum RR, et al. Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18490-5. doi: 10.1073/pnas.0809242105. Epub 2008 Nov 10. Proc Natl Acad Sci U S A. 2008. PMID: 19001271 Free PMC article.

Cite

Share

3

Cite

Share

Prostate-specific antigen screening: pro.

Loeb S, Catalona WJ. Loeb S, et al. Curr Opin Urol. 2010 May;20(3):185-8. doi: 10.1097/MOU.0b013e3283384047. Curr Opin Urol. 2010. PMID: 20224413 Free PMC article. Review.

Cite

Share

4

Cite

Share

TGF-β: duality of function between tumor prevention and carcinogenesis.

Principe DR, Doll JA, Bauer J, Jung B, Munshi HG, Bartholin L, Pasche B, Lee C, Grippo PJ. Principe DR, et al. J Natl Cancer Inst. 2014 Feb;106(2):djt369. doi: 10.1093/jnci/djt369. J Natl Cancer Inst. 2014. PMID: 24511106 Free PMC article. Review.

Cite

Share

5

Cite

Share

Therapeutic applications of extracellular vesicles: clinical promise and open questions.

György B, Hung ME, Breakefield XO, Leonard JN. György B, et al. Annu Rev Pharmacol Toxicol. 2015;55:439-464. doi: 10.1146/annurev-pharmtox-010814-124630. Epub 2014 Oct 3. Annu Rev Pharmacol Toxicol. 2015. PMID: 25292428 Free PMC article. Review.

Cite

Share

6

Cite

Share

Interrogating genomic and epigenomic data to understand prostate cancer.

Kim J, Yu J. Kim J, et al. Biochim Biophys Acta. 2012 Apr;1825(2):186-96. doi: 10.1016/j.bbcan.2011.12.003. Epub 2012 Jan 3. Biochim Biophys Acta. 2012. PMID: 22240201 Free PMC article. Review.

Cite

Share

7

Cite

Share

Androgen receptor genomic regulation.

Jin HJ, Kim J, Yu J. Jin HJ, et al. Transl Androl Urol. 2013 Sep;2(3):157-177. doi: 10.3978/j.issn.2223-4683.2013.09.01. Transl Androl Urol. 2013. PMID: 25237629 Free PMC article.

Cite

Share

8

Cite

Share

Mysteries of TGF-β Paradox in Benign and Malignant Cells.

Zhang Q, Yu N, Lee C. Zhang Q, et al. Front Oncol. 2014 May 13;4:94. doi: 10.3389/fonc.2014.00094. eCollection 2014. Front Oncol. 2014. PMID: 24860782 Free PMC article. Review.

Cite

Share

9

Cite

Share

A genetic-based approach to personalized prostate cancer screening and treatment.

Helfand BT, Catalona WJ, Xu J. Helfand BT, et al. Curr Opin Urol. 2015 Jan;25(1):53-8. doi: 10.1097/MOU.0000000000000130. Curr Opin Urol. 2015. PMID: 25405931 Free PMC article. Review.

Cite

Share

10

Cite

Share

Improving intermittent androgen deprivation therapy: lessons learned from basic and translational research.

Parikh RA, Pascal LE, Davies BJ, Wang Z. Parikh RA, et al. Asian J Androl. 2014 Jul-Aug;16(4):505-10. doi: 10.4103/1008-682X.125410. Asian J Androl. 2014. PMID: 24759577 Free PMC article. Review.

Cite

Share